Scientists have uncovered new genetic causes of sight loss, paving the way for a genetic diagnosis for thousands of people. 

Researchers, analysing data from Genomics England’s National Genomic Research Library (NGRL), found five new genetic causes of retinitis pigmentosa (RP), an eye condition that causes gradual blindness. 

The research, led by the University of Basel and Radboud University Medical Center, looked at the DNA and health data of over 4,700 individuals with RP. It found that changes in the RNU4-2 gene and changes in four RNU6 genes are linked to the condition.  

Scientists estimate these changes could provide answers for around 1.4% of unsolved RP cases around the world. 

RP is the most common cause of inherited sight loss and approximately two million people worldwide are affected. An estimated 30% to 50% of patients remain without a conclusive genetic diagnosis, even after genome sequencing is performed.  

“The changes that have been uncovered through this research could provide a genetic diagnosis for thousands of patients affected by genetic sight loss for the first time,” said Jamie Ellingford, lead genomic data scientist at Genomics England and one of the paper’s authors. 

“The discovery will help improve both the ability to diagnose [sight loss] as well as genetic counselling, which can be a very helpful resource for many people with a rare condition. 

“The genetic changes described for the first time in this study through whole genome sequencing data expand our understanding of the genetic basis of visual impairment and can now be integrated into standard genetic diagnostic testing.  

“The genes that have been uncovered are non-coding RNA genes – meaning they don’t make proteins. It’s more difficult to understand what effect changes in these types of genes have, and these findings increase evidence for the importance of non-coding RNA gene research. 

“These findings also provide a new avenue for research into developing treatments and genetic targets to focus on.” 

Analysis is ‘fundamental knowledge’ for hereditary disease research 

The findings, published in Nature Genetics, highlight that the RNU4-2 gene can lead to different genetic conditions depending on the specific change within the gene and where in the gene the change happens.  

As previously known, the RNU4-2 gene can cause neurodevelopmental disorders such as ReNU syndrome, a condition affecting learning, speech, movement and behaviour. However, changes in this same gene can lead to RP and gradual sight loss. 

RNU4-2 and RNU6 genes both create pieces of RNA that combine together, and with other genes, to help ensure that other genes can be ‘switched on’ and operate correctly. But when genetic changes impact RNU4-2 or the affected RNU6 genes in a way that stops them from fitting together, the retinal cells struggle to function over time and eventually stop working as well. This breakdown in the retina is what causes the vision problems associated with RP. 

“What makes this discovery particularly intriguing is that it involves one of the most fundamental cellular processes, RNA splicing, yet the disease manifests almost exclusively in the retina,” explained Carlo Rivolta, Head of the Ophthalmic Genetics Group at the Institute of Molecular and Clinical Ophthalmology Basel. 

“This shows how even subtle disturbances in core biological machinery can have highly specific effects in vulnerable tissues like photoreceptors.” 

“We’ve learned that changes in these RNA genes can be just as impactful as changes in protein-coding genes,” added Susanne Roosing, Molecular Geneticist at Radboudumc and Lead Researcher. 

“This is fundamental knowledge that broadens our understanding of hereditary diseases.” 

 

Bruno Quinney, Content Team, DDW